✦ LIBER ✦

Reduced-dose docetaxel for castration-resistant prostate cancer has no inferior impact on overall survival in Japanese patients

✍ Scribed by Kita, Yuki; Shimizu, Yosuke; Inoue, Takahiro; Kamba, Tomomi; Yoshimura, Koji; Ogawa, Osamu

Book ID: 121629421
Publisher: Springer
Year: 2012
Tongue: English
Weight: 216 KB
Volume: 18
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-012-0443-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic Impact of C-reactive Protein

Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel

✍ Masaya Ito; Kazutaka Saito; Yosuke Yasuda; Gen Sukegawa; Yuichi Kubo; Noboru Num 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Can docetaxel therapy improve overall su

Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study

✍ Tomoyuki Shimabukuro,Shigeru Sakano… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 231 KB

Re: Ito et al.: Prognostic Impact of C-r

Re: Ito et al.: Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel (Urology 2011;78:1131-1135)

✍ Rohit Kathpalia; Swarnendu Mandal; Satyanarayan Sankhwar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB

The effect of clinical trial participati

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer

✍ Jatinder Goyal; Philipp Nuhn; Peng Huang; Prachi Tyagi; Daniel Oh; Michael A. Ca 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

684 RADIUM-223 CHLORIDE (ALPHARADIN) IMP

684 RADIUM-223 CHLORIDE (ALPHARADIN) IMPACT ON OVERALL SURVIVAL AND SKELETAL-RELATED EVENTS IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER WITH BONE METASTASES A PHASE III RANDOMIZED TRIAL (ALSYMPCA)

✍ Sartor, Oliver; Heinrich, Daniel; Helle, Svein Inge; O'Sullivan, Joe M.; Chodack 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 50 KB

130 Overall survival benefit and impact

130 Overall survival benefit and impact on skeletal-related events for radium-223 chloride (Alpharadin) in the treatment of castration-resistant prostate cancer (CRPC) patients with bone metastases: A phase III randomized trial (ALSYMPCA)

✍ C. Parker; D. Heinrich; S.I. Helle; J.M O'Sullivan; S Fossä; A. Chodacki; T. Dem 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 107 KB